As the world leader of in vitro allergy diagnostics, Phadia, now Thermo Fisher Scientific, supplies seven out of ten allergy laboratory tests worldwide. ImmunoCAP offers a wide spectrum allergy testing technologies including point-of-care technology and high throughput technologies providing unmatched accuracy in the measurement of specific IgE antibody blood levels, as well as other important allergy risk markers. ImmunoCAP is one of the most important tools a clinician can utilize to truly understand allergy and aid in the diagnosis of symptoms associated with rhinitis, eczema, wheezing and asthma.
Laboratories and physicians rely on ImmunoCAP as the reference standard for in vitro allergy testing.
Some products on this website may only be available in certain countries. For more information, contact your local Phadia, now Thermo Fisher Scientific, representative.